???pagination.result.count???
Regulation of the neuronal KCNQ2 channel by Src--a dual rearrangement of the cytosolic termini underlies bidirectional regulation of gating. , Siloni S, Singer-Lahat D, Esa M, Tsemakhovich V, Chikvashvili D, Lotan I., J Cell Sci. September 15, 2015; 128 (18): 3489-501.
Novel KCNQ3 Mutation in a Large Family with Benign Familial Neonatal Epilepsy: A Rare Cause of Neonatal Seizures. , Maljevic S, Vejzovic S, Bernhard MK, Bertsche A, Weise S, Döcker M, Lerche H, Lemke JR, Merkenschlager A, Syrbe S., Mol Syndromol. September 1, 2016; 7 (4): 189-196.
KCNQ- SMIT complex formation facilitates ion channel-solute transporter cross talk. , Neverisky DL, Abbott GW., FASEB J. July 1, 2017; 31 (7): 2828-2838.
PIP2 mediates functional coupling and pharmacology of neuronal KCNQ channels. , Kim RY, Pless SA, Kurata HT., Proc Natl Acad Sci U S A. November 7, 2017; 114 (45): E9702-E9711.
Direct neurotransmitter activation of voltage-gated potassium channels. , Manville RW, Papanikolaou M, Abbott GW., Nat Commun. May 10, 2018; 9 (1): 1847.
Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket. , Manville RW, Abbott GW., Nat Commun. September 21, 2018; 9 (1): 3845.
Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels. , Manville RW, Abbott GW., Mol Pharmacol. October 1, 2018; 94 (4): 1155-1163.
One drug-sensitive subunit is sufficient for a near-maximal retigabine effect in KCNQ channels. , Yau MC, Kim RY, Wang CK , Li J, Ammar T, Yang RY, Pless SA, Kurata HT., J Gen Physiol. October 1, 2018; 150 (10): 1421-1431.
Deconstruction of an African folk medicine uncovers a novel molecular strategy for therapeutic potassium channel activation. , De Silva AM, Manville RW, Abbott GW., Sci Adv. November 14, 2018; 4 (11): eaav0824.
In silico re-engineering of a neurotransmitter to activate KCNQ potassium channels in an isoform-specific manner. , Manville RW, Abbott GW., Commun Biol. January 1, 2019; 2 401.
Epilepsy-associated mutations in the voltage sensor of KCNQ3 affect voltage dependence of channel opening. , Barro-Soria R., J Gen Physiol. February 4, 2019; 151 (2): 247-257.
M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate. , Manville RW, Papanikolaou M, Abbott GW., J Pharmacol Exp Ther. February 1, 2020; 372 (2): 148-156.
Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine. , Manville RW, Abbott GW., J Pharmacol Exp Ther. June 1, 2020; 373 (3): 391-401.
Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy. , Li J, Maghera J, Lamothe SM, Marco EJ, Kurata HT., Mol Pharmacol. September 1, 2020; 98 (3): 192-202.
Familial neonatal seizures caused by the Kv7.3 selectivity filter mutation T313I. , Maghera J, Li J, Lamothe SM, Braun M, Appendino JP, Au PYB, Kurata HT., Epilepsia Open. December 1, 2020; 5 (4): 562-573.
The Amyloid Precursor Protein C99 Fragment Modulates Voltage-Gated Potassium Channels. , Manville RW, Abbott GW., Cell Physiol Biochem. July 28, 2021; 55 (S3): 157-170.
Distinctive mechanisms of epilepsy-causing mutants discovered by measuring S4 movement in KCNQ2 channels. , Edmond MA, Hinojo-Perez A, Wu X, Perez Rodriguez ME, Barro-Soria R., Elife. June 1, 2022; 11